These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27412989)

  • 21. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial.
    Kim BK; Hong SJ; Lee YJ; Hong SJ; Yun KH; Hong BK; Heo JH; Rha SW; Cho YH; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Jang Y; Hong MK;
    Lancet; 2022 Jul; 400(10349):380-390. PubMed ID: 35863366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial.
    Lee YJ; Lee SH; You SC; Lee YH; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Kim JS
    Diabetes Obes Metab; 2024 Mar; 26(3):829-839. PubMed ID: 37994242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of coadministration of ezetimibe and statins in patients with hypercholesterolaemia: a meta-analysis.
    Luo L; Yuan X; Huang W; Ren F; Zhu H; Zheng Y; Tang L
    Intern Med J; 2015 May; 45(5):546-57. PubMed ID: 25644680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Lee SJ; Joo JH; Park S; Kim C; Choi DW; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Nam CM; Hong MK
    J Am Coll Cardiol; 2023 Aug; 82(5):401-410. PubMed ID: 37495276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease).
    Fras Z; Mikhailidis DP
    Curr Vasc Pharmacol; 2021; 19(5):451-468. PubMed ID: 32720602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COMBINATION THERAPY EFFECTIVENESS OF EZETIMIBE AND ATORVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROME.
    Japaridze L; Sadunishvili M; Megreladze I
    Georgian Med News; 2016 Mar; (252):15-22. PubMed ID: 27119829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Kato ET; Cannon CP; Blazing MA; Bohula E; Guneri S; White JA; Murphy SA; Park JG; Braunwald E; Giugliano RP
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.
    Hong SJ; Jeong HS; Ahn JC; Cha DH; Won KH; Kim W; Cho SK; Kim SY; Yoo BS; Sung KC; Rha SW; Shin JH; Han KR; Chung WS; Hyon MS; Lee HC; Bae JH; Rhee MY; Kwan J; Jeon DW; Yoo KD; Kim HS
    Clin Ther; 2018 Feb; 40(2):226-241.e4. PubMed ID: 29402522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.
    Chang SH; Wu LS; Lee CH; Kuo CT; Liu JR; Wen MS; Chen WJ; See LC; Yeh YH
    Int J Cardiol; 2015; 190():20-5. PubMed ID: 25912112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Lin YC; Lai TS; Wu HY; Chou YH; Chiang WC; Lin SL; Chen YM; Chu TS; Tu YK
    Clin Pharmacol Ther; 2020 Oct; 108(4):833-843. PubMed ID: 32320058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis.
    Kim BG; Lee SJ; Lee YJ; You SC; Hong SJ; Yun KH; Hong BK; Heo JH; Rha SW; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Cho YH; Kim JS
    Sci Rep; 2023 Nov; 13(1):20157. PubMed ID: 37978309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.
    Ara R; Tumur I; Pandor A; Duenas A; Williams R; Wilkinson A; Paisley S; Chilcott J
    Health Technol Assess; 2008 May; 12(21):iii, xi-xiii, 1-212. PubMed ID: 18485273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial.
    Bonaca MP; Gutierrez JA; Cannon C; Giugliano R; Blazing M; Park JG; White J; Tershakovec A; Braunwald E
    Lancet Diabetes Endocrinol; 2018 Dec; 6(12):934-943. PubMed ID: 30396865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis.
    Pintaningrum Y; Aditya Putra Pramana KA
    J Pak Med Assoc; 2024 Jun; 74(6 (Supple-6)):S23-S27. PubMed ID: 39018135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial.
    Lee YJ; Cho JY; You SC; Lee YH; Yun KH; Cho YH; Shin WY; Im SW; Kang WC; Park Y; Lee SY; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Kim JS
    Eur Heart J; 2023 Mar; 44(11):972-983. PubMed ID: 36529993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.
    Abramson BL; Benlian P; Hanson ME; Lin J; Shah A; Tershakovec AM
    Lipids Health Dis; 2011 Aug; 10():146. PubMed ID: 21859459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study.
    Punekar RS; Fox KM; Paoli CJ; Richhariya A; Cziraky MJ; Gandra SR; Toth PP
    Curr Med Res Opin; 2017 May; 33(5):869-876. PubMed ID: 28276256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial.
    Amarenco P; Kim JS; Labreuche J; Charles H; Giroud M; Lee BC; Lavallée PC; Mahagne MH; Meseguer E; Nighoghossian N; Steg PG; Vicaut É; Bruckert E;
    Stroke; 2022 Nov; 53(11):3260-3267. PubMed ID: 36154103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Efficacy and Safety of Statin-Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies.
    Shin KH; Choi HD
    Am J Cardiovasc Drugs; 2022 Jul; 22(4):395-406. PubMed ID: 34927215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.